Discovery of Imidazo[1,2-<i>b</i>]pyridazine Derivatives: Selective and Orally Available Mps1 (TTK) Kinase Inhibitors Exhibiting Remarkable Antiproliferative Activity

Ken‐ichi Kusakabe(Futaba (Japan)), Yusuke Nakamura(Rissho University), Yataro Daigo(The University of Tokyo), Masayo Higaki(Shiga University of Medical Science), Motofumi Iguchi(Futaba (Japan)), Genta Tadano(Futaba (Japan)), Nobuyuki Ide(Futaba (Japan)), Hiroshi Hashizume(Futaba (Japan)), Shingo Sakamoto(Shiga University of Medical Science), Shigeru Ando(Futaba (Japan)), Yasuto Kido(Shiga University of Medical Science), Sachie Tagashira(Futaba (Japan)), Hiroshi Yoshida(Futaba (Japan)), Yuji Sato(Futaba (Japan)), Takeshi Itoh(Futaba (Japan)), Keiji Dohi(Futaba (Japan)), Takayuki Kanazawa(Futaba (Japan)), Takahiko Yamamoto(Shiga University of Medical Science), Kenichi Higashino(Shiga University of Medical Science), Yoshiyasu Baba(Futaba (Japan)), Y. Okano(Shiga University of Medical Science), Yukichi Ishioka(Futaba (Japan)), Kohei Nozu(Futaba (Japan)), Makiko Inoue(Howard Hughes Medical Institute), Masahiro Maeda(Shiga University of Medical Science)
Journal of Medicinal Chemistry
January 27, 2015
Cited by 64


Related Papers